0001628280-26-016805
SEC filingFoghorn Therapeutics Inc. filed an 8-K on March 11, 2026, furnishing Item 2.02 with Exhibit 99.1 Press Release and Item 7.01 with Exhibit 99.2 Investor Presentation. These items are not deemed filed under Section 18 of the Securities Exchange Act of 1934.